Literature DB >> 17095281

[Interest of selective lymphadenectomy in patients with vulvar cancer].

O Pape1, P Lopès, R Bouquin, S Evrard, C Ansquer, C Laboisse, H-J Philippe.   

Abstract

Vulvar cancer represents approximately 4% of all gynecologic malignancies and the most important prognosis factor in this cancer is the status of the regional lymph nodes. The radical inguinal lymphadenectomy, associated or not with radiotherapy, is accompanied by high morbidity, which can affect 50% of the patients. The sentinel node detection appears now to be feasible in patients with vulvar carcinoma, in order to reduce the morbidity of inguinal lymphadenectomy. But contrary to breast cancer, the learning curve is not easy to obtain because of the low number of cases. That is why we have described the procedure of selective lymphadenectomy. The aim of this technique is to remove the blue and/or marked inguinal lymph node and any other palpable lymph node, without a real radical inguinal lymphadenectomy. Thus, since November 2003, 4 procedures have been performed in total. With the lymphoscintigraphy, we identified 17 marked lymph node and we finally obtained 28 lymph nodes after surgery, with only one metastatic lymph node. There was no complication after our procedure. Selective lymphadenectomy appears to be a new procedure which may reduce the morbidity of usual inguinal lymphadenectomy.

Entities:  

Mesh:

Year:  2006        PMID: 17095281     DOI: 10.1016/j.gyobfe.2006.10.009

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  2 in total

1.  [Verrucous carcinoma of the vulva: report of four cases].

Authors:  Majdouline Boujoual; Hafid Hachi; Mouna Rimani; Basma El Khannoussi; Abdesslam Bougtab
Journal:  Pan Afr Med J       Date:  2014-04-21

2.  [Case study of vulvar malignant melanoma conducted at the Cinquantenaire General Hospital in Lubumbashi].

Authors:  Gabriel Kapya Mukeya; Ivan Mwandwe Kakoka; Joseph Chola Mwansa; Willy Arung Kalau
Journal:  Pan Afr Med J       Date:  2020-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.